Patients' dissatisfaction with multifocal intraocular lenses managed by exchange with other multifocal lenses of different optical profiles.
Journal
Eye and vision (London, England)
ISSN: 2326-0254
Titre abrégé: Eye Vis (Lond)
Pays: England
ID NLM: 101664982
Informations de publication
Date de publication:
01 Mar 2022
01 Mar 2022
Historique:
received:
19
07
2021
accepted:
08
02
2022
entrez:
1
3
2022
pubmed:
2
3
2022
medline:
2
3
2022
Statut:
epublish
Résumé
The aim of the study was to evaluate the outcomes of dissatisfied patients reporting poor visual quality following implantation of multifocal intraocular lenses (MF-IOLs), managed by IOL exchange with another multifocal optical profile. This is a retrospective series of cases. MF-IOL exchange was done in 15 dissatisfied patients (30 eyes) with the perception of poor visual quality for far distance affected by neuroadaptation failure. Patients underwent a bilateral exchange of a MF-IOL with another MF-IOL of a different optical profile. Visual outcomes and complications were analyzed. Questionnaires including Quality of Vision (QoV), Visual Function Index-14 (VF-14) and its Rasch-revised version (VF-8R) and a satisfaction questionnaire were also used for outcome evaluation. The mean elapsed time from implantation to explantation-reimplantation was 11.8 months. The QoV scores improved significantly across all the three subscales. Visual function improved with a change in VF-14 score from 60.41 ± 24.81 to 90.16 ± 10.91 (P < 0.001). The VF-8R score improved as well. The uncorrected distance visual acuity improved from 0.24 to 0.12 logMAR after exchange (P < 0.001) and corrected distance visual acuity improved from 0.15 to 0.04 logMAR (P < 0.001). Safety and efficacy indexes reached 1.46 and 1.16, respectively. Concerning patients' satisfaction following MF-IOL exchange, 80% of the patients reported they would have the MF-IOL reimplantation procedure again. Patient dissatisfaction with neuroadaptation failure following MF-IOL implantation can be managed in 80% of our cases by MF-IOL exchange with a different MF-IOL optical profile.
Sections du résumé
BACKGROUND
BACKGROUND
The aim of the study was to evaluate the outcomes of dissatisfied patients reporting poor visual quality following implantation of multifocal intraocular lenses (MF-IOLs), managed by IOL exchange with another multifocal optical profile.
METHODS
METHODS
This is a retrospective series of cases. MF-IOL exchange was done in 15 dissatisfied patients (30 eyes) with the perception of poor visual quality for far distance affected by neuroadaptation failure. Patients underwent a bilateral exchange of a MF-IOL with another MF-IOL of a different optical profile. Visual outcomes and complications were analyzed. Questionnaires including Quality of Vision (QoV), Visual Function Index-14 (VF-14) and its Rasch-revised version (VF-8R) and a satisfaction questionnaire were also used for outcome evaluation.
RESULTS
RESULTS
The mean elapsed time from implantation to explantation-reimplantation was 11.8 months. The QoV scores improved significantly across all the three subscales. Visual function improved with a change in VF-14 score from 60.41 ± 24.81 to 90.16 ± 10.91 (P < 0.001). The VF-8R score improved as well. The uncorrected distance visual acuity improved from 0.24 to 0.12 logMAR after exchange (P < 0.001) and corrected distance visual acuity improved from 0.15 to 0.04 logMAR (P < 0.001). Safety and efficacy indexes reached 1.46 and 1.16, respectively. Concerning patients' satisfaction following MF-IOL exchange, 80% of the patients reported they would have the MF-IOL reimplantation procedure again.
CONCLUSIONS
CONCLUSIONS
Patient dissatisfaction with neuroadaptation failure following MF-IOL implantation can be managed in 80% of our cases by MF-IOL exchange with a different MF-IOL optical profile.
Identifiants
pubmed: 35227312
doi: 10.1186/s40662-022-00280-8
pii: 10.1186/s40662-022-00280-8
pmc: PMC8887122
doi:
Types de publication
Journal Article
Langues
eng
Pagination
8Subventions
Organisme : instituto de salud carlos iii
ID : RD16/0008/0012
Informations de copyright
© 2022. The Author(s).
Références
Eur J Ophthalmol. 2012 Sep-Oct;22(5):762-8
pubmed: 22610718
J Cataract Refract Surg. 2010 Jul;36(7):1181-8
pubmed: 20610098
J Cataract Refract Surg. 2013 Apr;39(4):590-7
pubmed: 23395326
J Refract Surg. 2019 Jun 1;35(6):346-352
pubmed: 31185099
J Cataract Refract Surg. 2005 Oct;31(10):1960-5
pubmed: 16338567
J Cataract Refract Surg. 2016 Sep;42(9):1262-1267
pubmed: 27697243
J Cataract Refract Surg. 2011 May;37(5):859-65
pubmed: 21397457
J Refract Surg. 2020 Dec 1;36(12):796-803
pubmed: 33295991
J Cataract Refract Surg. 2009 Oct;35(10):1706-10
pubmed: 19781463
J Cataract Refract Surg. 2015 Apr;41(4):873-7
pubmed: 25840309
Optom Vis Sci. 2013 Aug;90(8):760-4
pubmed: 23792364
Acta Ophthalmol. 2014 May;92(3):265-9
pubmed: 23648070
J Cataract Refract Surg. 2009 Jun;35(6):1013-8
pubmed: 19465286
J Cataract Refract Surg. 2017 Oct;43(10):1287-1296
pubmed: 29120714
J Refract Surg. 2019 Jul 1;35(7):408-416
pubmed: 31298720
J Refract Surg. 2012 May;28(5):313; author reply 313-4
pubmed: 22589323
J Cataract Refract Surg. 2004 Dec;30(12):2494-503
pubmed: 15617915
J Cataract Refract Surg. 2020 Dec;46(12):1596-1603
pubmed: 33259388
Curr Opin Ophthalmol. 2008 Jan;19(1):18-21
pubmed: 18090892
Clin Ophthalmol. 2020 Sep 29;14:2903-2911
pubmed: 33061276
BMC Ophthalmol. 2018 Nov 9;18(1):293
pubmed: 30413145
J Cataract Refract Surg. 2017 Jun;43(6):761-766
pubmed: 28732609
J Cataract Refract Surg. 2020 Mar;46(3):388-393
pubmed: 32142039
Ophthalmology. 2017 Sep;124(9):1280-1289
pubmed: 28433446
Acta Med Okayama. 2012;66(2):101-10
pubmed: 22525468
Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5537-45
pubmed: 20505205
J Cataract Refract Surg. 2009 Jun;35(6):992-7
pubmed: 19465282
Invest Ophthalmol Vis Sci. 2012 Jun 26;53(7):4042-54
pubmed: 22618597
Am J Ophthalmol. 2014 Jan;157(1):154-162.e1
pubmed: 24182744
J Cataract Refract Surg. 2008 Sep;34(9):1584-91
pubmed: 18721724
Am J Ophthalmol. 2014 Aug;158(2):215-220.e1
pubmed: 24792105
J Ophthalmol. 2020 Apr 27;2020:6143832
pubmed: 32411432